BLSM — BLOSSOMHILL THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying BLSM?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 2 tracked investors who changed their BLSM position last quarter, 2 bought and 0 sold (100% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 45/100 in a Overheat regime).
- +2 tracked investors added or increased positions last quarter (Izzy Englander, Ken Griffin)
- +2 tracked investors reported holding BLSM at their latest filing
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/17/2026.
About BLOSSOMHILL THERAPEUTICS INC (BLSM)
BLOSSOMHILL THERAPEUTICS INC (BLSM) appears in the most recent 13F filings of 2 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $1M. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BLSM
How many top investors track BLSM
Only 2 tracked investors report this position.
BLSM Ownership Composition
How BLOSSOMHILL THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting BLSM
- Ken GriffinSep 30, 2026Citadel AdvisorsShares55KValue$1M% Portfolio0.00%
- Izzy EnglanderSep 30, 2026Millennium ManagementShares45.8KValue$854K% Portfolio0.00%
Recent activity
- $854KNov 16, 2026
- New$1MNov 16, 2026
Frequently asked questions
- How many institutional investors hold BLSM?
- 2 tracked institutional investors disclosed a position in BLSM (BLOSSOMHILL THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of BLSM?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in BLSM, valued at $1M.
- Did institutional ownership of BLSM increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited BLSM.
- Where does this BLSM ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.